Combination of Prescription Diabetes Drugs Boosts Risk of Cardiovascular Death

Email this article to a friend

Printable Version

Articles Related to This Article: • American Diabetes Association peddling nutritional nonsense while accepting money from manufacturer of candy and sodas • Chemical Causes of Diabetes: Overeating Is Not the Only Problem • Chromium prevents diabetes by improving insulin sensitivity NaturalNews Store Specials: • Revolutionary new Hurom Slow Juicer at the lowest price on the 'net + FREE shipping! • Certified Organic Nutiva Hemp Seeds at a huge discount (+ FREE bottle of hemp oil) • Omega-3 rich Chia Seeds at under $5 / lb. See more at the NN store...

(NaturalNews) Patients undergoing combination treatment with two different classes of diabetes drugs may be at increased risk of cardiovascular death, death from other causes, or hospitalization due to cardiovascular disease, according to a study conducted by researchers from Tulane University School of Medicine and published in the journal Diabetes Care.

The researchers reviewed data from nine previously published studies that looked at rates of hospitalization and death in more than 101,000 Type 2 diabetes patients being treated with a combination of any drug in the sulfonylurea family along with metformin, a drug in the biguanide family.

They found that patients undergoing combination therapy were 19 percent more likely to die from any cause and 29 percent more likely to die from cardiovascular disease than patients being treated with only one diabetes drugs or with diet therapy alone. While these increases did not achieve statistical significance, the researchers also found a 43 percent increase in the risk of cardiovascular disease-related death or hospitalization that was statistically significant.

"So it appears that there is some increased risk with this combination that is the most widely used diabetes treatment of two drugs that are cheap and generic," said lead researcher Vivian A. Fonseca.

The researchers originally found 299 studies conducted between January 1966 and July 2007 that examined the connection between combination drug therapy and cardiovascular mortality in diabetics. Only nine of the studies were found to contain enough data to be included in the meta-analysis, however.

"The paper highlights a real dilemma we have today in diabetes treatment," Fonseca said. "We have drugs that lower glucose but we seem to run into problems over time with improving outcomes - particularly cardiovascular outcomes."

Diabetes is a major risk factor for cardiovascular disease, which is the United States' top killer. According to the American Diabetes Association, approximately 26 million people in the United States currently suffer from diabetes.

Sources for this story include: uk.reuters.com.

Share

Get articles like this delivered to you FREE in our popular email newsletter

Related CounterThink Cartoons:

Related Articles: • American Diabetes Association peddling nutritional nonsense while accepting money from manufacturer of candy and sodas • Chemical Causes of Diabetes: Overeating Is Not the Only Problem • Chromium prevents diabetes by improving insulin sensitivity	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/025678_diabetes_risk_drugs.html Reprinting this article: Non-commercial use OK, cite NaturalNews.com with clickable link. Embed article link: (copy HTML code below): <a href = "http://www.NaturalNews.com/025678_diabetes_risk_drugs.html">Combination of Prescription Diabetes Drugs Boosts Risk of Cardiovascular Death</a>